1.Optic Canal Fractures.
Duk Kee HAHN ; Shin Dong KIM ; Choon Sup OH
Journal of the Korean Ophthalmological Society 1973;14(2):112-115
The optic canal fracture has been recognized as a clinical entity for quite sometime, and is, by no means, a rare condition. We were aware of it for last several years, and have collected five radiographically proved cases from the records. Interestingly enough, two of these patients were involved in motor-cycle accidents and revealed abrasion over the lateral end of the homolateral eye brow. Only one of these five patients had partial recovery of his vision.
Humans
2.Therapeutic Efficacy of Meropenem for Treatment of Experimental Penicillin-Resistant Pneumococcal Meningitis.
Shin Woo KIM ; Joung Hwa JIN ; Soo Jung KANG ; Sook In JUNG ; Yeon Sook KIM ; Choon Kwan KIM ; Hyuck LEE ; Won Sup OH ; Sungmin KIM ; Kyong Ran PECK ; Jae Hoon SONG
Journal of Korean Medical Science 2004;19(1):21-26
With the widespread emergence of antimicrobial resistance, combination regimens of ceftriaxone and vancomycin (C+V) or ceftriaxone and rifampin (C+R) are recommended for empirical treatment of pneumococcal meningitis. To evaluate the therapeutic efficacy of meropenem (M), we compared various treatment regimens in arabbit model of meningitis caused by penicillin-resistant Streptococcus pneumoniae (PRSP). Therapeutic efficacy was also evaluated by the final bacterial concentration in the cerebrospinal fluid (CSF) at 24 hr. Each group consisted of six rabbits. C+V cleared the CSF at 10 hr, but regrowth was noted in 3 rabbits at 24 hr. Meropenem monotherapy resulted in sterilization at 10 hr, but regrowth was observed in all 6 rabbits at 24 hr. M+V also resulted in sterilization at 10 hr, but regrowth was observed in 2 rabbits at 24 hr. M+V was superior to the meropenem monotherapy at 24 hr (reduction of 4.8 vs. 1.8 log10 cfu/mL, respectively; p=0.003). The therapeutic efficacy of M+V was comparable to that of C+V (reduction of 4.8 vs. 4.0 log10 cfu/mL, respectively; p=0.054). The meropenem monotherapy may not be a suitable choice for PRSP meningitis, while combination of meropenem and vancomycin could be a possible alternative in the treatment of PRSP meningitis.
Animals
;
Anti-Bacterial Agents/pharmacology
;
Cerebrospinal Fluid
;
Disease Models, Animal
;
*Drug Resistance, Microbial
;
Human
;
Male
;
Meningitis, Pneumococcal/*drug therapy
;
Penicillins/*pharmacology
;
Rabbits
;
Streptococcus pneumoniae
;
Support, Non-U.S. Gov't
;
Thienamycins/*pharmacology
;
Time Factors
3.Clinical Characteristics of Pyogenic Liver Abscess with Klebsiella pneumoniae or Non-Klebsiella pneumoniae and Its Prognosis Associated with Diabetes Mellitus.
Seong Ill WOO ; Hyeok Choon KWON ; Young Hwa CHOI ; Seung Soo SHIN ; Chang Oh KIM ; Hyo Youl KIM ; Yoon Seon PARK ; Yoon Soo PARK ; Young Goo SONG ; Joon Sup YEOM ; Hee Jung YOON ; Kkot Sil LEE ; Sung Ho CHOI ; Jun Yong CHOI ; Sung Kwan HONG ; June Myung KIM
Infection and Chemotherapy 2006;38(2):77-84
BACKGROUND: Although the most common pathogen of liver abscess was Escherichia coli in the past, there has been an increasing number of reports on liver abscess caused by Klebsiella pneumoniae, especially in Asia and its more frequent occurrence in diabetes mellitus. Our study was to clarify the different clinical characteristics and prognostic factors of K. pneumoniae and non-K. pneumoniae liver abscess in patients with or without diabetes. MATERIALS AND METHODS: We reviewed medical records of pyogenic liver abscess diagnosed by defined criteria at 7 different tertiary care hospitals in Seoul and Gyeonggi Province from January 2000 to December 2003 retrospectively. RESULTS: Of the 248 cases, 86 cases (34.7%) of patients were diabetic. Cryptogenic cause (73.4%) was the most frequent portal of entry in liver abscess and 58 cases (23.4%) were the secondary following biliary disease. There were no differences in portal of entry between DM group and non- DM group. The most common organism was K. pneumoniae (70.2%) followed by E. coli (11.5%) and alpha-hemolytic streptococcus (5.2%). There were no significant differences in causative organism of liver abscess between DM group and non-DM group as K. pneumoniae was dominant pathogen [76.6% in DM group vs 66.2% in non-DM group (P=0.11)]. The metastatic complication occurred in 15 cases (8.6%) and found more frequently in DM group (P=0.042). All of the metastatic abscesses were found in liver abscess caused by K. pneumoniae (P=0.007). Ten patients died and the overall mortality rate was 4.1%. The factors associated with mortality were level of serum creatinine, past history of intra-abdominal surgery and underlying biliary malignancy. CONCLUSION: The most commom pathogen of the pyogenic liver abscess is K. pneumoniae and the metastatic complications are usually found in liver abscess caused by K. pneumoniae, especially more frequently in patients with diabetes than in patients without diabetes.
Abscess
;
Asia
;
Creatinine
;
Diabetes Mellitus*
;
Escherichia coli
;
Gyeonggi-do
;
Humans
;
Klebsiella pneumoniae*
;
Klebsiella*
;
Liver Abscess
;
Liver Abscess, Pyogenic*
;
Medical Records
;
Mortality
;
Pneumonia*
;
Prognosis*
;
Retrospective Studies
;
Seoul
;
Streptococcus
;
Tertiary Healthcare
4.Clinical Characteristics of Pyogenic Liver Abscess with Klebsiella pneumoniae or Non-Klebsiella pneumoniae and Its Prognosis Associated with Diabetes Mellitus.
Seong Ill WOO ; Hyeok Choon KWON ; Young Hwa CHOI ; Seung Soo SHIN ; Chang Oh KIM ; Hyo Youl KIM ; Yoon Seon PARK ; Yoon Soo PARK ; Young Goo SONG ; Joon Sup YEOM ; Hee Jung YOON ; Kkot Sil LEE ; Sung Ho CHOI ; Jun Yong CHOI ; Sung Kwan HONG ; June Myung KIM
Infection and Chemotherapy 2006;38(2):77-84
BACKGROUND: Although the most common pathogen of liver abscess was Escherichia coli in the past, there has been an increasing number of reports on liver abscess caused by Klebsiella pneumoniae, especially in Asia and its more frequent occurrence in diabetes mellitus. Our study was to clarify the different clinical characteristics and prognostic factors of K. pneumoniae and non-K. pneumoniae liver abscess in patients with or without diabetes. MATERIALS AND METHODS: We reviewed medical records of pyogenic liver abscess diagnosed by defined criteria at 7 different tertiary care hospitals in Seoul and Gyeonggi Province from January 2000 to December 2003 retrospectively. RESULTS: Of the 248 cases, 86 cases (34.7%) of patients were diabetic. Cryptogenic cause (73.4%) was the most frequent portal of entry in liver abscess and 58 cases (23.4%) were the secondary following biliary disease. There were no differences in portal of entry between DM group and non- DM group. The most common organism was K. pneumoniae (70.2%) followed by E. coli (11.5%) and alpha-hemolytic streptococcus (5.2%). There were no significant differences in causative organism of liver abscess between DM group and non-DM group as K. pneumoniae was dominant pathogen [76.6% in DM group vs 66.2% in non-DM group (P=0.11)]. The metastatic complication occurred in 15 cases (8.6%) and found more frequently in DM group (P=0.042). All of the metastatic abscesses were found in liver abscess caused by K. pneumoniae (P=0.007). Ten patients died and the overall mortality rate was 4.1%. The factors associated with mortality were level of serum creatinine, past history of intra-abdominal surgery and underlying biliary malignancy. CONCLUSION: The most commom pathogen of the pyogenic liver abscess is K. pneumoniae and the metastatic complications are usually found in liver abscess caused by K. pneumoniae, especially more frequently in patients with diabetes than in patients without diabetes.
Abscess
;
Asia
;
Creatinine
;
Diabetes Mellitus*
;
Escherichia coli
;
Gyeonggi-do
;
Humans
;
Klebsiella pneumoniae*
;
Klebsiella*
;
Liver Abscess
;
Liver Abscess, Pyogenic*
;
Medical Records
;
Mortality
;
Pneumonia*
;
Prognosis*
;
Retrospective Studies
;
Seoul
;
Streptococcus
;
Tertiary Healthcare
5.Current Status of Prophylaxis for Endocarditis.
Hyun Kyun KI ; Sun Hee KIM ; Kyung Mok SOHN ; Yu Mi WI ; Ji Young RHEE ; Chi Sook MOON ; Won Sup OH ; Kyong Ran PECK ; Eun Suk JEON ; Nam Yong LEE ; Jun Seop YEOM ; Choon Kwan KIM ; Jun Sung SON ; Yeon Suk KIM ; Suk In JUNG ; Hyun Ha JANG ; Shin Woo KIM ; Hyuck LEE ; Jae Hoon SONG
Korean Circulation Journal 2005;35(4):328-334
BACKGROUND AND OBJECTIVES: Antibiotic prophylaxis of infective endocarditis is required before high-risk procedures in patient with high-risk heart diseases. Although guidelines for the prevention of infective endocarditis were proposed by the American Heart Association in 1997, compliance to these recommendations has not been evaluated in Korea. SUBJECTS AND METHODS: This was a retrospective, multicentered study in 8 Korean university hospitals. Patients with high-risk heart diseases, having undergone invasive dental procedures between Jan. 1, 2000 and Dec. 31, 2003, were enrolled. The medical and dental records of the patients were reviewed to evaluate whether the prophylaxis had been appropriate. RESULTS: Of the initial 4,912 patients, 184 that had been treated with invasive dental procedures (255 total episodes, mean 1.4/patient) were evaluated. The most common high-risk heart disease was a prosthetic heart valve (233 procedures), followed by a previous history of infective endocarditis (22 procedures), cyanotic heart diseases (5 procedures) and systemic pulmonic venous shunts (2 procedures). Antibiotic prophylaxis was performed in 231 procedures (90.8%). Amoxicillin was the most common antibiotic used for prophylaxis (88.6%); however, the adequate dosage (2 gm) was administered in only 56% of these cases. Therefore, the appropriate prophylaxis, according to the AHA recommendations, was performed in only 14.1% (36 procedures). The mean duration of prophylaxis and number of antibiotic doses were 2.40 days (2.40+/-2.44) and 7.97 doses (7.97+/-7.18), respectively. A previous history of infective endocarditis (p=0.03) and dental extraction (p<0.01) resulted in a longer duration of prophylaxis. CONCLUSION: Only 14.1% of the high risk group procedures were given appropriate antibiotic prophylaxis according to the AHA recommendations. These data suggest that protocol-based education of both doctors and patients is required for appropriate antimicrobial therapy during high-risk procedures for the prevention of infective endocarditis in patients with high-risk heart disease.
American Heart Association
;
Amoxicillin
;
Antibiotic Prophylaxis
;
Compliance
;
Dental Records
;
Education
;
Endocarditis*
;
Heart Diseases
;
Heart Valves
;
Hospitals, University
;
Humans
;
Korea
;
Retrospective Studies